Novo Nordisk Operating Expenses 2010-2024 | NVO

Novo Nordisk operating expenses for the twelve months ending September 30, 2024 were $22.138B, a 26.63% increase year-over-year.

  • Novo Nordisk annual operating expenses for 2023 were $18.831B, a 30.19% increase from 2022.
  • Novo Nordisk annual operating expenses for 2022 were $14.464B, a 10.65% increase from 2021.
  • Novo Nordisk annual operating expenses for 2021 were $13.071B, a 17.17% increase from 2020.

Novo Nordisk Operating Expenses 2010-2024 | NVO

  • Novo Nordisk annual operating expenses for 2023 were $18.831B, a 30.19% increase from 2022.
  • Novo Nordisk annual operating expenses for 2022 were $14.464B, a 10.65% increase from 2021.
  • Novo Nordisk annual operating expenses for 2021 were $13.071B, a 17.17% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$692.7B
Johnson & Johnson (JNJ)$368.4B
AbbVie (ABBV)$294.4B
Merck (MRK)$244.2B
Novartis AG (NVS)$211.1B
AstraZeneca (AZN)$197.8B
Pfizer (PFE)$142.2B
Sanofi (SNY)$121.8B
Innoviva (INVA)$1.2B